3M Company (MMM) Market Cap & Valuation Ratios
3M Company (MMM) has a market cap of $89.6B, a trailing P/E of 25.9 and a price-to-sales ratio of 3.5, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
MMM3M CompanyFollow MMM — free
—
Price chart with a free account
- Market cap
- 89.6B
- P/E TTM
- 25.9
- Dividend yield
- 1.8%
- 52-week
- —
- Next earnings
- 18 Jan, in 86 days
Peers
conglomerates · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| MMM | 90 | 25.9 | 4.0 | 16.2 | 3.0% | +2% | 19% | 28% |
| HON | 70 | — | 2.4 | 8.5 | 1.4% | -9% | 22% | 20% |
| VMI | 8.4 | 17.0 | 2.1 | 13.4 | 3.8% | +4% | 14% | 24% |
| OTTR | 3.8 | 19.5 | 3.6 | 13.7 | -2.1% | +0.3% | 17% | 8% |
| SEB | 3.7 | 5.9 | 0.4 | 6.1 | -0.6% | +8% | 3% | 4% |
| BBUC | 2.4 | — | 1.6 | 12.7 | — | -10% | 1% | 0.5% |
| DLX | 1.1 | 10.7 | 1.1 | 6.1 | 19.6% | +0.3% | 12% | 8% |
| TTI | 0.8 | 177.7 | 1.3 | 9.7 | -1.9% | +6% | 7% | 9% |
| CODI | 0.8 | — | 1.3 | 11.1 | 10.2% | -5% | 3% | 2% |
| MATW | 0.6 | — | 1.0 | 9.4 | -13.6% | -32% | 6% | 5% |
| TRC | 0.4 | 71.5 | 9.2 | 84.0 | 0.3% | +25% | -0.9% | -0.1% |
| Median of these 10 | 18.2 | 1.5 | 10.4 | 0.3% | +0.3% | 7% | 7% |
P/E 25.9 vs. a peer median of 18.2; EV/Sales 4.0 vs. 1.5. MMM's own P/E sits at the 76th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesHON and BBUC and CODI and MATW have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
3M Company — questions
- What is 3M Company's market cap?
- $89.6B.
- What is 3M Company's P/E ratio?
- 25.9 on trailing twelve-month earnings to 2026-09-30.
- What is 3M Company's price-to-sales ratio?
- 3.5.
Every figure on this page comes from 3M Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.